Quick viewing(Text Mode)

Coronavirus Disease 2019 (COVID-19) Situation Report

Coronavirus Disease 2019 (COVID-19) Situation Report

Coronavirus Disease 2019 (COVID-19) World Health CoronavirusCoronavirus Disease Disease 2019 2019 (COVID (COVID-19) -19) World Health OrganizationOrganization Situation Report - 57 Situationn Report - 7 Indonesia

2 JuneData 2021 as of 07 May 2020

HIGHLIGHTS

• As of 2 June, the reported 1 831 773 (5246 new) confirmed cases of COVID-19, 50 908 (185 new) deaths and 1 680 501 recovered cases from 510 districts across all 34 provinces.1

• WHO supported the National Institute of Health Research and Development (NIHRD) to conduct supportive supervision to provincial hospital laboratories that conduct polymerase chain reaction testing for COVID-19 in (page 18).

• WHO continues to support the Ministry of Health in conducting rapid response team training for region and presented ‘Rapid Risk Assessment of Acute Public Health Events’ during the session on 31 May (pages 19-20).

Fig. 1. Geographic distribution of cumulative number of confirmed COVID-19 cases in Indonesia across the provinces reported from 27 May to 2 June 2021. Source of data

Disclaimer: Data are not available for province for this time period due to internet connectivity issues2. The number of cases reported daily is not equivalent to the number of persons who contracted COVID-19 on that day; reporting of laboratory-confirmed results may take up to one week from the time of testing.

1 https://covid19.go.id/peta-sebaran-covid19 2 https://www.cnnindonesia.com/nasional/20210519005740-20-644032/internet-mati-di-papua-ganggu-rekap- data-covid-19-vaksinasi 1 WHO Indonesia Situation Report - 57 who.int/indonesia GENERAL UPDATES

• Indonesia recorded a surge in the number of COVID-19 cases and clusters of COVID-19 infection, one week following the Eid al-Fitr holidays. The National COVID-19 Task Force (Satuan Tugas (Satgas)) reported that from 17 to 23 May, the weekly average number of confirmed cases increased by 36.1% compared to the previous week. As of the same week, Satgas also reported that the number of COVID-19 deaths increased by 13.8%. In addition, a low level of public compliance to health protocols was reported since the beginning of the second week of Ramadan, as many public places were crowded with visitors.3

• The Government of Indonesia resumed COVID-19 vaccination using the AstraZeneca COVID-19 vaccine from the CTMAV547 batch, which was temporarily suspended over safety concerns. The batch is comprised of 448 480 vaccine doses, which was part of the 3.8 million doses from the COVAX Facility that arrived in April. On 27 May, the Ministry of Health (MoH) announced that according to the findings from further tests conducted by the National Agency of Drug and Food Control (Badan Pengawas Obat dan Makanan (BPOM)), the vaccines from this batch are safe to be used. BPOM concluded that the batch meets the requirements in terms of quality during distribution and storage.4

• On 27 May, MoH announced that locally transmitted SARS-CoV-2 variants of concern (VoC) were detected in 19 cases across the country. These included the variants that were first identified in the United Kingdom (B.1.1.7 variant), South Africa (B.1.351) and (B.1.617). These cases were found in North , , DKI , West , , South and .5

• On 25 May, Bio Farma reported that 77 000 doses of COVID-19 vaccine from Sinopharm have been distributed for the ‘Gotong Royong’ private vaccination programme. Around 22 000 doses have been administered. As the initial stage, Indonesia received 500 000 doses of COVID-19 vaccine from Sinopharm in May. Bio Farma stated that another one million doses of the vaccine are scheduled to be sent to the country during the first week of June. In total, Indonesia will receive 15 million doses of vaccine from Sinopharm, which will be delivered in stages.6

3 https://www.thejakartapost.com/news/2021/05/29/post-idul-fitri-covid-19-surge-imminent-with-daily-case-rise- new-clusters.html 4 https://www.thejakartapost.com/paper/2021/05/28/government-resumes-use-of-astrazeneca-vaccines-after- clot-scare.html 5 https://go.kompas.com/read/2021/05/27/194016674/indonesia-detects-19-locally-transmitted-cases-of-mutant- covid-strains-deputy?page=all#page2 6 https://en.tempo.co/read/1465804/bio-farma-distributes-77000-doses-of-sinopharm-vaccine-for-private- vaccination 2 WHO Indonesia Situation Report - 57 who.int/indonesia SURVEILLANCE

• On 2 June, 5246 new and 1 831 773 cumulative confirmed COVID-19 cases were reported nationwide (Fig. 2). The average for the last seven days from 27 May to 2 June was 5793 cases per day, compared to 5446 cases per day reported in the previous week.

16000 2000000

14000 1800000 1600000 12000 1400000 10000 1200000 8000 1000000

Daily numberDaily 6000 800000

600000 number Cumulative 4000 400000 2000 200000

0 0

6-Jul

2-Jan

4-Oct

7-Apr 2-Apr

7-Feb

24-Jul

9-Nov

2-Mar

8-May

20-Jan

18-Jun

22-Oct

20-Apr 25-Apr

16-Sep 25-Feb

15-Dec

11-Aug 29-Aug

27-Nov

20-Mar 15-Mar

31-May 13-May 26-May

Daily number of confirmed COVID-19 cases Cumulative number of confirmed COVID-19 cases

Fig. 2. Daily and cumulative number of cases reported in Indonesia, as of 2 June 2021. Source of data

Disclaimer: The number of cases reported daily is not the number of persons who contracted COVID-19 on that day and might be influenced by the number of people tested on that day (see Fig. 16); reporting of laboratory-confirmed results may take up to one week from the time of testing. Therefore, caution must be taken in interpreting this figure and the epidemiological curve for further analysis, either at the national or subnational level.

3 WHO Indonesia Situation Report - 57 who.int/indonesia • During the week of 24 to 30 May, the provinces that experienced an increase in the number of weekly cases of more than 50% compared to the previous week were West Nusa Tenggara (189%), (71%), (63%), Islands (62%), (57%), (54%), (53%) and (51%) (Fig. 3). It is critical to investigate reasons for the increase in new confirmed cases to guide response decisions and inform the adjustment of public health and social measures (PHSM).

West Nusa Tenggara Aceh Maluku Central Sulawesi Gorontalo Jambi Central Java Riau South Sumatra DKI Jakarta Central Kalimantan DI Bali -100% -50% 0% 50% 100% 150% 200% 250% Percentage change of weekly number of confirmed cases

Fig. 3. Percentage change of weekly number of confirmed cases by province during 24 to 30 May 2021 compared to the previous week. Source of data

Disclaimer: Data are not available for Papua province for this time period due to internet connectivity issues2. The number of weekly confirmed cases is calculated taking into consideration the daily number of reported cases. It is important to conduct further investigation if there is a substantial change in new cases, especially in provinces with a change of 50% or more. Other factors, such as testing and contact tracing, may help elucidate the reasons behind substantial changes. Additional indicators, including case incidence and mortality, should be considered to guide adjustment of PHSM.

4 WH O Indonesia Situation Report - 57 who.int/indonesia

• During the week of 24 to 30 May, the incidence7 of COVID-19 in Indonesia increased to 12.5 per 100 000 population, compared to 11.3 per 100 000 in the previous week (Fig. 4).

35

30

CT2 (20 - <50) 25

20

15 Case Case incidence 10 CT1 (<20)

5

0

22/06 - 28/0622/06- 12/0706/07- 13/0419/04- 27/0403/05- 11/0517/05- 25/0531/05- 08/0614/06- 20/0726/07- 03/0809/08- 17/0823/08- 31/0806/09- 14/0920/09- 28/0904/10- 12/1018/10- 26/1001/11- 09/1115/11- 23/1129/11- 07/1213/12- 21/1227/12- 04/0110/01- 18/0124/01- 01/0207/02- 15/0221/02- 01/0307/03- 15/0321/03- 29/0304/04- 12/0418/04- 26/0402/05- 10/0516/05- 24/0530/05-

Fig. 4. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period reported in Indonesia from 13 April 2020 (when Indonesia first reported community transmission in the country) to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

Disclaimer: There are seven categories for transmission classification: (1) no (active) cases; (2) imported/sporadic cases; (3) cluster of cases; (4) community transmission 1 (CT1); (5) community transmission 2 (CT2); (6) community transmission 3 (CT3); and (7) community transmission 4 (CT4). Caution should be exercised when interpreting this indicator due to limitations listed in the WHO interim guidance. Other epidemiological indicators also need to be evaluated to decide on the level of community transmission. This disclaimer applies to indicators at national (Fig. 4) and subnational levels (Figs. 5 to 11).

7 Weekly incidence of COVID-19 is calculated as the number of new cases per 100 000 population per week averaged over a two-week period. Source of population data 5 WHO Indonesia Situation Report - 57 who.int/indonesia

• During the week of 24 to 30 May, the incidence rates of COVID-19 per 100 000 population were 71.3 in Bangka Belitung Islands and 61.7 in Riau Islands; these rates correspond to community transmission level 3 (Fig. 5). Based on WHO interim guidance, community transmission level 3 means that there is a high risk of COVID-19 infection for the general population and that a high number of locally acquired, widely dispersed cases was detected in the past 14 days.

Bangka Belitung Islands Riau Islands Riau DKI Jakarta DI Yogyakarta West Sumatra North Kalimantan Central Kalimantan Aceh East Kalimantan West Java West Kalimantan Bengkulu Bali Central Java South Sumatra Jambi South Kalimantan West Papua Lampung West Nusa Tenggara North Sumatra East Nusa Tenggara East Java Banten Central Sulawesi Maluku North Maluku Gorontalo South Sulawesi North Sulawesi Southeast Sulawesi West Sulawesi 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 Weekly case incidence

CT 1 (<20) CT 2 (20-<50) CT 3 (50 - <150) CT 4 (150+)

Fig. 5. Data are not available for Papua province for this time period due to internet connectivity issues2. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period by province in Indonesia during 24 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

6 WH O Indonesia Situation Report - 57 who.int/indonesia • During the week of 24 to 30 May, the weekly incidence of COVID-19 increased in most provinces in Java-Bali, compared to the incidence in the previous week (Fig. 6).

Fig. 6. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period in Java - Bali, from 13 April 2020 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

7 WHO Indonesia Situation Report - 57 who.int/indonesia • The weekly incidence of COVID-19 increased in all provinces in Sumatra during the week of 24 to 30 May compared to the previous week. There has been an increasing trend in case incidence since early April in most provinces in Sumatra, with a peak in incidence in Aceh and Riau Islands in the most recent week (Fig. 7).

Fig. 7. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period in Sumatra, from 13 April 2020 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

8 WHO Indonesia Situation Report - 57 who.int/indonesia

• During the week of 24 to 30 May, the weekly incidence of COVID-19 increased in all provinces in Kalimantan compared to the incidence in the previous week, except for South Kalimantan which remained the same. There has been a notable increasing trend in West Kalimantan since the beginning of 2021, with a peak in case incidence in the last week (Fig. 8).

Fig. 8. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period in Kalimantan, from 13 April 2020 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

9 WHO Indonesia Situation Report - 57 who.int/indonesia • In Sulawesi, the weekly incidence of COVID-19 increased in the provinces of South Sulawesi and Gorontalo during the period of 24 to 30 May compared to the previous week (Fig. 9).

Fig. 9. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period in Sulawesi, from 13 April 2020 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

10 WHO Indonesia Situation Report - 57 who.int/indonesia • During the week of 24 to 30 May, the weekly incidence of COVID-19 increased in West Nusa Tenggara, Maluku and North Maluku compared to the previous week (Fig. 10).

Fig. 10. Incidence of COVID-19 per 100 000 population per week averaged over a two-week period in West Nusa Tenggara, East Nusa Tenggara, Maluku, North Maluku, Papua, and West Papua, from 13 April 2020 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

Disclaimer: Data are not available for Papua province as of 13 May due to internet connectivity issues2.

• Nationwide test positivity proportion increased sharply after 23 November and

reached a peak of 30.5% in mid-February. Subsequently, the positivity proportion declined and stood at 9.9% on 30 May, which is considered as CT3 (high incidence) (Fig. 11). However, the percentage of positive samples can be interpreted reliably

only with comprehensive surveillance and testing in the order of one person tested per 1000 population per week. This minimum case detection benchmark was achieved in DKI Jakarta and DI Yogyakarta for the last three weeks. Nevertheless,

these provinces still have a test positivity proportion of more than 5%, which means that transmission is still high in the community (Fig. 12).

11 WHO Indonesia Situation Report - 57 who.int/indonesia 40%

35%

CT 4 (20%+) 30%

25%

20% CT 3 (5% - <20%)

15% Positivity Positivity proportion(%)

10%

5% CT 2 (2% - <5%)

CT 1 (<2%) 0% 1-May 1-Jun 1-Jul 1-Aug 1-Sep 1-Oct 1-Nov 1-Dec 1-Jan 1-Feb 1-Mar 1-Apr 1-May

Fig. 11. Test positivity proportion averaged over a two-week period at the national level in Indonesia, as of 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data Disclaimer: Caution should be exercised when interpreting this indicator due to limitations listed in the WHO interim guidance. Other epidemiological indicators also need to be evaluated to determine the level of community transmission.

12 WHO Indonesia Situation Report - 57 who.int/indonesia 7.00 55.0% 50.0% 6.00 45.0% 5.00 40.0% 35.0% 4.00 30.0% 3.00 25.0% 20.0% 2.00 15.0%

10.0% Positivity proportion(%) 1.00 5.0%

People People tested/1000 population/week - 0.0% 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 Indonesia DKI West Central DI Yogyakarta East Banten Jakarta Java Java Java

People tested/1000 population/week Test positivity proportion

7.00 55.0% 50.0% 6.00 45.0% 5.00 40.0% 35.0% 4.00 30.0% 3.00 25.0% 20.0% 2.00 15.0%

10.0% Positivity proportion(%) 1.00 5.0%

People People tested/1000 population/week - 0.0% 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 1 2 3 Indonesia West East West Riau Central South Southeast Sumatra Kalimantan Papua Kalimantan Sumatra Sulawesi

People tested/1000 population/week Test positivity proportion

Fig. 12. Test positivity proportion and people tested per 1000 population per week at the national level and in select provinces.

Week 1: 10/05/21 to 16/05/21; Week 2: 17/05/21 to 23/05/21; Week 3: 24/05/21 to 30/05/21 Benchmark: one person tested per 1000 population per week Threshold test positivity proportion: <5% Source of data: Indonesia, DKI Jakarta, West Java, Central Java, DI Yogyakarta, East Java, Banten, West Sumatra, East Kalimantan, West Papua, Riau, Central Kalimantan, South Sumatra, Southeast Sulawesi

Note: Due to a limitation in data, other provinces could not be evaluated. For surveillance purposes, test positivity proportion is calculated as the number of confirmed cases divided by the number of people tested for diagnosis.

13 WHO Indonesia Situation Report - 57 who.int/indonesia

• During the week of 24 to 30 May, Riau had the highest weekly number of confirmed COVID-19 deaths per 100 000 population, followed by DI Yogyakarta, DKI Jakarta, Riau Islands and Bangka Belitung Islands (Fig. 13).

Riau DI Yogyakarta DKI Jakarta Riau Islands Bangka Belitung Islands West Sumatra West Papua Aceh Bali South Sumatra Central Java Central Kalimantan North Sulawesi East Kalimantan Jambi South Kalimantan East Java Lampung West Kalimantan Central Sulawesi West Java West Nusa Tenggara North Kalimantan East Nusa Tenggara North Sumatra Banten Maluku Bengkulu South Sulawesi Southeast Sulawesi Gorontalo North Maluku West Sulawesi 0.0 0.5 1.0 1.5 2.0 Weekly number of confirmed COVID-19 deaths per 100 000 population

CT 1 (<1) CT 2 (1 - <2) CT 3 (2 - <5) CT 4 (5+)

Fig. 13. Number of confirmed COVID-19 deaths per 100 000 population per week averaged over a two-week period by province in Indonesia during 24 to 30 May 2021, classified by level of community transmission (CT): CT1: low incidence; CT2: moderate incidence; CT3: high incidence; CT4: very high incidence. Source of data

Disclaimer: Data are not available for Papua province for this time period due to internet connectivity issues2. Based on data availability, only confirmed COVID-19 deaths have been included. As per WHO definition, however, death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause of death that cannot be related to COVID-19 (e.g. trauma); there should be no period of complete recovery between the illness and death.

14 WHO Indonesia Situation Report - 57 who.int/indonesia

• At the national level, during the week of 24 to 30 May, the number of confirmed COVID-19 deaths was 0.41 per 100 000 population8, compared to 0.43 per 100 000 in the previous week (Fig. 14).

0.8

0.7

0.6

0.5

0.4

0.3

0.2

Deaths Deaths per 000 100 population 0.1

0.0

06/07 - 12/0706/07- 20/0914/09- 29/1123/11- 13/0419/04- 27/0403/05- 11/0517/05- 25/0531/05- 08/0614/06- 22/0628/06- 20/0726/07- 03/0809/08- 17/0823/08- 31/0806/09- 28/0904/10- 12/1018/10- 26/1001/11- 09/1115/11- 07/1213/12- 21/1227/12- 04/0110/01- 18/0124/01- 01/0207/02- 15/0221/02- 01/0307/03- 15/0321/03- 29/0304/04- 12/0418/04- 26/0402/05- 10/0516/05- 24/0530/05-

Fig. 14. Number of confirmed COVID-19 deaths per 100 000 population per week averaged over a two-week period in Indonesia, as of 30 May 2021. Source of data

Disclaimer: Based on data availability, only confirmed COVID-19 deaths have been included. As per WHO definition, however, death resulting from a clinically compatible illness in a probable or confirmed COVID-19 case is a COVID-19-related death, unless there is a clear alternative cause of death that cannot be related to COVID-19 (e.g. trauma); there should be no period of complete recovery between the illness and death. Evaluation of the level of community transmission could not be conducted due to data limitations.

• During the week of 24 to 30 May, the total number of weekly confirmed COVID-19 deaths in DKI Jakarta was 102, compared to 125 in the previous week (Fig. 15).

8 Weekly mortality of COVID-19 is calculated as the number of COVID-19 deaths per 100 000 population per week averaged over a two-week period. Source of population data 15 WHO Indonesia Situation Report - 57 who.int/indonesia DKI Jakarta 350

300 19 19 deaths

- 250

200

150

100

50

0

Weekly Weekly number confirmed of COVID

02/0308/03- 16/0322/03- 30/0305/04- 13/0419/04- 27/0403/05- 11/0517/05- 25/0531/05- 08/0614/06- 22/0628/06- 06/0712/07- 20/0726/07- 03/0809/08- 17/0823/08- 31/0806/09- 14/0920/09- 28/0904/10- 12/1018/10- 26/1001/11- 09/1115/11- 23/1129/11- 07/1213/12- 21/1227/12- 04/0110/01- 18/0124/01- 01/0207/02- 15/0221/02- 01/0307/03- 15/0321/03- 29/0304/04- 12/0418/04- 26/0402/05- 10/0516/05- 24/0530/05-

Fig. 15. Weekly number of confirmed COVID-19 deaths in DKI Jakarta, as of 30 May 2021.Source of data,

Disclaimer: The data are provisional. There may be a discrepancy in the number of deaths in confirmed COVID-19 cases between national and provincial data sources.

HEALTH OPERATIONS

• As reported on 2 June, the daily number of people tested for COVID-19 was 49 731 and the cumulative number of people tested was 11 352 639 (Fig. 16).

16 WHO Indonesia Situation Report - 57 who.int/indonesia 80000 12000000 70000 10000000 60000 8000000 50000 40000 6000000 30000

Daily number Daily 4000000

20000 number Cumulative 2000000 10000

0 0

7-Jan

5-Jun

9-Oct

7-Apr

3-Sep

2-Dec

11-Jul 29-Jul

7-Mar 2-Mar

25-Jan

23-Jun

27-Oct

25-Apr 12-Apr 30-Apr

21-Sep 12-Feb

20-Dec

16-Aug

14-Nov

25-Mar 20-Mar

18-May 13-May 31-May Daily number of people tested Cumulative number of people tested

Fig. 16. Daily and cumulative number of people tested for COVID-19 in Indonesia, as of 2 June 2021. Source of data

• As of 2 June, the proportion of people recovered among the total confirmed COVID-19 cases was 91.7% and there were 100 364 active cases (Fig. 17).

200000 100.0 180000 90.0

160000 80.0 140000 70.0 120000 60.0 100000 50.0

Number 80000 40.0

60000 30.0 (%) Percentage 40000 20.0 20000 10.0

0 0.0

8-Jun

5-Oct

1-Apr

1-Sep 1-Feb

12-Jul 29-Jul

8-Nov

7-Mar

5-May

15-Jan

25-Jun

22-Oct

18-Apr 10-Apr 27-Apr

18-Sep 18-Feb

12-Dec 29-Dec

15-Aug

25-Nov

24-Mar

22-May 14-May 31-May Active cases Recovery percentage Fig. 17. Number of active cases of COVID-19 and recovery percentage in Indonesia, as of 2 June 2021. Source of data

17 WHO Indonesia Situation Report - 57 who.int/indonesia

• The reported number of confirmed COVID-19 cases hospitalized in DKI Jakarta reached a peak of 9888 hospitalized cases on 12 February. The number of hospitalized cases subsequently decreased and remained relatively stable, with an average of 3362 hospitalized cases per day in March and April. There was an increasing trend in May, with 5417 hospitalized cases reported on 31 May (Fig. 18).

10000 9000

8000

19 19 cases - 7000 6000 5000

4000 hospitalized 3000 2000

1000 Number confirmed of COVID 0 1-Sep 1-Oct 31-Oct 30-Nov 30-Dec 29-Jan 28-Feb 30-Mar 29-Apr 29-May

Fig. 18. Number of confirmed COVID-19 cases hospitalized in DKI Jakarta from 1 September 2020 to 31 May 2021. Source of data

LABORATORY

• As part of the effort to improve the quality of COVID-19 polymerase chain reaction (PCR) testing in the country, WHO supported the National Institute of Health Research and Development (NIHRD) to conduct field visits and supportive supervision to provincial hospital laboratories in West Nusa Tenggara from 27 to 29 May. During the visits, NIHRD conducted an evaluation of the performance of laboratories and a root cause analysis (RCA), the findings of which were discussed to formulate follow-up actions and a strategy to improve PCR testing in the province. In addition, NIHRD made arrangements for the preparation of the distribution of external quality assessment (EQA) panels for the third phase of the assessment. NIHRD plans to distribute EQA panels to 650 participating laboratories across the country in mid-July.

18 WHO Indonesia Situation Report - 57 who.int/indonesia RISK COMMUNICATION

• WHO continues to translate important courses designed for key partners and frontline responders into Indonesian, also available on the OpenWHO platform. As of 1 June, there have been 28 571 enrolments in the eight OpenWHO courses available in Indonesian.

Table 1. Number of participants enrolled in the OpenWHO courses that have been translated into Indonesian, as of 1 June 2021.

Number of No. OpenWHO courses participants enrolled Infection Prevention and Control (IPC) for 1. 8316 COVID-19 virus 2. ePROTECT Respiratory Infections 6685 COVID-19: Operational Planning Guidelines and 3. COVID-19 Partners Platform to support country 3813 preparedness and response Introduction to COVID-19: methods for detection, 4. 3443 prevention, response and control 5. COVID-19 vaccination training for health workers 2551 WHO Clinical Care Severe Acute Respiratory 6. 1304 Infection Training Severe Acute Respiratory Infection (SARI) 7. 1272 Treatment Facility Design Long-term care facilities in the context of 8. 1187 COVID-19

• WHO is regularly translating and sharing important health messages on its website and social media platforms – Twitter and Instagram – and continues to published Infographics useful for the public.

RISK AND NEEDS ASSESSMENT, AND PLANNING

• WHO continues to support MoH in conducting rapid response team (RRT) training for the Sulawesi region. The 'Rapid Risk Assessment of Acute Public Health Events' guide was presented by WHO during an online training session on 31 May. A rapid risk assessment is a systematic process of gathering, assessing and documenting information to assign a level of risk based on the analysis of hazard, exposure and context to guide the response to public health events. The session was attended by 36 participants from points of entry and provincial health offices (PHOs) across the region. Through a combination of online and offline sessions, participants will be trained on surveillance, detection of emerging infectious 19 WHO Indonesia Situation Report - 57 who.int/indonesia diseases (EID) (including field investigation and response to EID), specimen collection, shipment and laboratory testing, case management and infection control and risk communication. The online component of the training has been ongoing since 24 May and will be conducted in batches until 5 June. Offline sessions will be conducted from 7 to 11 June. At the end of the training, participants will partake in a simulation exercise to test their capabilities to detect new SARS-CoV-2 variants and respond to the simulated event.

VACCINATION

• As of 31 May, 27 256 388 vaccine doses have been administered in the national COVID-19 vaccination campaign; 16 558 536 people have received the first dose and 10 697 852 people have received the second dose (Fig. 19). 18000000 16000000 14000000 12000000 10000000 8000000 6000000 4000000 Number vaccinated 2000000

0

4-Apr 8-Apr

3-Feb 7-Feb

3-Mar 7-Mar

2-May 6-May

22-Jan 26-Jan 30-Jan

12-Apr 16-Apr 20-Apr 24-Apr 28-Apr

11-Feb 15-Feb 19-Feb 23-Feb 27-Feb

19-Mar 11-Mar 15-Mar 23-Mar 27-Mar 31-Mar

18-May 10-May 14-May 22-May 26-May 30-May

Cumulative 1st dose vaccination Cumulative 2nd dose vaccination

Fig. 19. Cumulative number of vaccine doses administered in Indonesia, from 22 January to 31 May 2021. Source of data

Disclaimer: COVID-19 vaccination started on 13 January. Published data from MoH is available starting from 22 January.

• As of 31 May, the number of health workers who have received the second dose of the COVID-19 vaccine (fully vaccinated) was 1 386 778 (94.4% of the target population of 1 468 764). The number of older people who have received the first dose of the vaccine was 3 340 338 (15.5% of the targeted 21 553 118); 2 198 723 (10.2% of the targeted population) have received the second dose. The number of essential public service workers who have received the first dose of the vaccine was 11 663 306 (67.3% of the targeted 17 327 167); 7 111 644 (41% of the target population) have received the second dose of the vaccine (Fig. 20). As part of the essential public service workers priority target group, 1 598 502 teachers have received the first dose of the vaccine; 995 401 have received the second dose. 20 WHO Indonesia Situation Report - 57 who.int/indonesia 1518202 Health Workers 1386778 1st dose 2nd dose 3340338 Older people 2198723

Essential public service 11663306 workers 7111644

0 2000000 4000000 6000000 8000000 10000000 12000000 Number of people who have received COVID-19 vaccine Fig. 20. Cumulative number of people who have received COVID-19 vaccine in Indonesia, as of 31 May 2021. Source of data

Disclaimer: COVID-19 vaccination started with health workers on 13 January. The second stage of COVID-19 vaccination started on 17 February, targeting essential public service workers and older people (above 60 years old). Published data from MoH is available starting from 22 January.

• As of 31 May, the highest coverage of the first dose vaccination administered to eligible target populations in the country was in Bali, followed by DKI Jakarta, Riau Islands, DI Yogyakarta and East Java. As of the same day, Bali had the highest coverage of the second dose vaccination administered, followed by DKI Jakarta, DI Yogyakarta, Bangka Belitung Islands and East Kalimantan (Fig. 21).

180% 160% 140% 120% 100% 80% 60% 40% 20%

Vaccination coverage (%) 0%

Bali

Riau

Aceh

Jambi

Papua

Banten

Maluku

EastJava

Lampung

Bengkulu

West Java West

Gorontalo

DKI Jakarta DKI

Riau Islands Riau

Central Java Central

West Papua West

DI Yogyakarta DI

NorthMaluku

West Sulawesi West

South Sulawesi South

NorthSulawesi

West SumateraWest

NorthSumatera

EastKalimantan

South Sumatera South

Central Sulawesi Central

West Kalimantan West

South Kalimantan South

NorthKalimantan

SoutheastSulawesi

Central Kalimantan Central

East Nusa Tenggara EastNusa

West NusaTenggara West Bangka Belitung Islands Belitung Bangka

1st dose coverage (%) 2nd dose coverage (%) Target Fig. 21. COVID-19 vaccination coverage among the eligible target populations by province in Indonesia, as of 31 May 2021. Source of data

Disclaimer: Vaccination coverage over 100% is due to differences in actual versus estimated target population.

21 WHO Indonesia Situation Report - 57 who.int/indonesia

• As of 31 May, the number of people vaccinated with at least one dose of the vaccine per 100 population nationwide was 6.1. As of the same day, Bali had the highest number of people vaccinated with at least one dose of the vaccine (29.2 per 100 population) amongst all provinces, followed by DKI Jakarta (23.3) (Fig. 22).

<5 5-<10 ≥10

Fig. 22. Number of people vaccinated with at least one dose of the vaccine per 100 population by province in Indonesia, as of 31 May 2021. Source of data

• As of 31 May, DKI Jakarta had the highest coverage of first and second dose vaccination to older people (Fig. 23). As of the same day, provinces with the highest number of unvaccinated older people were West Java, Central Java and East Java (Fig. 24)

100% 90% 80% 70% 60% 50% 40% 30% 20% 10%

Vaccination coverage (%) 0%

Bali

Riau

Aceh

Jambi

Papua

Banten

Maluku

EastJava

Lampung

Bengkulu

West Java West

Gorontalo

DKI Jakarta DKI

Riau Islands Riau

Central Java Central

West Papua West

DI Yogyakarta DI

NorthMaluku

West Sulawesi West

South Sulawesi South

NorthSulawesi

West SumateraWest

NorthSumatera

EastKalimantan

South Sumatera South

Central Sulawesi Central

West Kalimantan West

South Kalimantan South

NorthKalimantan

SoutheastSulawesi

Central Kalimantan Central

East Nusa Tenggara EastNusa

West NusaTenggara West Bangka Belitung Islands Belitung Bangka

1st dose (coverage) 2nd dose (coverage) Target (coverage) Fig. 23. COVID-19 vaccination coverage of older people by province in Indonesia, as of 31 May 2021. Source of data 22 WH O Indonesia Situation Report - 57 who.int/indonesia

West Java Central Java East Java North Sumatera Banten South Sulawesi Lampung South Sumatera Riau Aceh West Sumatera East Nusa Tenggara West Kalimantan West Nusa Tenggara DKI Jakarta South Kalimantan Jambi Papua East Kalimantan Central Sulawesi Bali Southeast Sulawesi Central Kalimantan DI Yogyakarta North Sulawesi Riau Islands Bengkulu Maluku West Sulawesi Bangka Belitung Islands North Maluku Gorontalo West Papua North Kalimantan 0 800000 1600000 2400000 3200000 4000000 4800000

Unvaccinated

Fig. 24. Number of unvaccinated older people (over 60 years of age) by province in Indonesia, as of 24 May 2021. Source of data

23 WHO Indonesia Situation Report - 57 who.int/indonesia

PARTNER COORDINATION

• On 28 May, WHO convened the 31st meeting of key development partners to discuss and coordinate the COVID-19 response among partners in Indonesia. The meeting was attended by partners, including the Asian Development Bank (ADB), British Embassy, the Australian Government Department of Foreign Affairs and Trade (DFAT), the European Union (EU), Japan International Cooperation Agency (JICA), United Nations Children’s Fund (UNICEF), United States Centers for Disease Control and Prevention (US CDC), the World Bank and the World Food Programme (WFP). WHO presented COVID-19 updates, discussed the latest epidemiological situation at national and subnational levels, and explained the key WHO interventions to support the national pandemic response. Several key points of discussion among partners included the potential surge of cases following the Eid holidays, updates on the SARS-CoV-2 variants detected in the country, findings from the oxygen survey and updates on COVID-19 vaccination programmes.

• The overall funding request for WHO operations and technical assistance is US$ 46 million (US$ 27 million for response and US$ 19 million for recovery phase), based on estimated needs as of June 2021 (Fig. 25).

Fig. 25. WHO funding situation for COVID-19 response, June 2021.

Data presented in this situation report have been taken from publicly available data from the MoH (https://infeksiemerging.kemkes.go.id/), COVID-19 Mitigation and National Economic Recovery Team (KPCPEN) (http://covid19.go.id) and provincial websites. There may be differences in national and provincial data depending on the source used. All data are provisional and subject to change. 24 WHO Indonesia Situation Report - 57 who.int/indonesia RECENT AND UPCOMING WHO RESOURCE MATERIALS

Table 2: Title and details of recent WHO resource materials Source: https://www.who.int/ Title Details Operational guide for Contact tracing is a key component of a public health response engaging to infectious disease outbreaks. The purpose of this guide is to communities in reinforce the place of community engagement and participation contact tracing, in the contact tracing process. This guide and related products 28 May 2021 articulate best practice principles for community engagement and how they can be operationalized as part of any community-centred contact tracing strategy. Critical This document is an update to the interim guidance of the same preparedness, title, which was originally published on 22 March 2020 and readiness and previously updated on 5 November 2020. This current version response actions for provides updated guidance on contact tracing, laboratory COVID-19 (interim testing, infection prevention and control (IPC), PHSM and guidance), 27 May health services in the context of COVID-19 vaccination 2021 implementation. This document outlines critical preparedness, readiness and response actions that are necessary, depending on the SARS-CoV-2 transmission scenario. Where possible, transmission scenario should be assessed at the lowest administrative level within each country. Episode 40 of The WHO Director of Health Emergency Information and Risk Science in 5, WHO’s Assessment Department Dr Oliver Morgan explains series of SARS-CoV-2 transmission and precautionary steps to keep conversations in safe indoors and outdoors. science, 27 May 2021 Technical note on The global supply of ChAdOx1-[recombinant] vaccines is delayed shipments presently constrained, which impacts country access to for the ChAdOx1-S ChAdOx1-S [recombinant] vaccine (AstraZeneca COVID-19 [recombinant] vaccine AZD1222, SII Covishield, SK Bioscience). The vaccines: what are uncertainty of future supply has prompted countries to review the implications for policy and programmatic implications, as providing the second the administration of dose of the vaccine within the WHO recommended 8-12 week second doses? schedule may not be feasible in the near future. This document (scientific brief), supplements information provided in 'Considerations for 26 May 2021 optimizing deployment of ChAdOx1-2 [recombinant] vaccines in a time-limited constrained supply situation' and provides updated information relevant to the provision of a second dose in the current limited supply context.

25 WHO Indonesia Situation Report - 57 who.int/indonesia A SNAPSHOT OF WHO COURSES AND INFORMATION MATERIAL

Online WHO COVID-19 courses: • COVID-19 vaccination training for health workers • Standard precautions: Environmental cleaning and disinfection • Management of COVID-19 in long-term care facilities • Operational planning guidelines and COVID-19 • Clinical management of severe acute respiratory infections • Health and safety briefing for respiratory diseases – eProtect

WHO guidance: • Preventing and mitigating COVID-19 at work (policy brief) • COVID-19 Vaccine Introduction and Deployment Costing tool (CVIC tool) • Health worker communication for COVID-19 vaccination flow diagram • Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic • Continuity of essential health services: Facility assessment tool (interim guidance) • COVID-19 natural immunity (scientific brief) • Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (CNBG), Sinopharm - Interim guidance

Infographics: • Celebrating Eid al-Fitr • Self-isolation • How to make a fabric mask • Contact tracing

Questions and answers: • COVID-19: Vaccines • COVID-19: Vaccine research and development • COVID-19: Vaccine access and allocation

Videos: • Science in 5: Evolution of the SARS-CoV-2 virus • Time to abide (1-10) • COVID-19 virus variants

For more information please feel free to contact: [email protected] WHO Indonesia Reports 26 WHO Indonesia Situation Report - 57 who.int/indonesia

Top View